MAPK1 and breast cancer: However, our findings showing the importance of ERK dimerization for the motility and metastatic dissemination of mammary tumor cells, open an interesting venue for the future development of ERK dimerization inhibitors, either by directly targeting ERK–ERK interaction [17] or ERK‐KSR1 association [2].